{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:06Z","timestamp":1778861406422,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012116","name":"European Bioinformatics Institute","doi-asserted-by":"publisher","award":["PRJEB81483"],"award-info":[{"award-number":["PRJEB81483"]}],"id":[{"id":"10.13039\/100012116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012116","name":"European Bioinformatics Institute","doi-asserted-by":"publisher","award":["48\/ISG\/24"],"award-info":[{"award-number":["48\/ISG\/24"]}],"id":[{"id":"10.13039\/100012116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RC 2025"],"award-info":[{"award-number":["RC 2025"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jgar.2025.04.010","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:13:21Z","timestamp":1745842401000},"page":"111-119","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Cefiderocol activity against planktonic and biofilm forms of \u03b2-lactamase-producing pseudomonas aeruginosa from people with cystic fibrosis"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8775-9094","authenticated-orcid":false,"given":"Giorgia","family":"Fabrizio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3046-3922","authenticated-orcid":false,"given":"Mauro","family":"Truglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Cavallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Sivori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3133-9237","authenticated-orcid":false,"given":"Massimo","family":"Francalancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodolfo J.","family":"Riveros Cabral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manola","family":"Comar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Trancassini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8254-1164","authenticated-orcid":false,"given":"Daniele Emanuele","family":"Compagnino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Diaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2533-2939","authenticated-orcid":false,"given":"Guido","family":"Antonelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiorentina","family":"Ascenzioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fulvia","family":"Pimpinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enea Gino","family":"Di Domenico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2025.04.010_bib0001","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jcf.2016.05.007","article-title":"Cystic fibrosis in Latin America\u2014Improving the awareness","volume":"15","author":"Silva Filho","year":"2016","journal-title":"J Cystic Fibro"},{"key":"10.1016\/j.jgar.2025.04.010_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic Fibrosis","volume":"42","author":"Dickinson","year":"2021","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.jgar.2025.04.010_bib0003","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S2213-2600(12)70057-7","article-title":"A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect","volume":"1","author":"Boyle","year":"2013","journal-title":"Lancet Respiratory Med"},{"key":"10.1016\/j.jgar.2025.04.010_bib0004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.molmed.2007.05.001","article-title":"Cystic fibrosis: a disease of vulnerability to airway surface dehydration","volume":"13","author":"Boucher","year":"2007","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jgar.2025.04.010_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019970","article-title":"Dysfunctional CFTR alters the bactericidal activity of Human macrophages against Pseudomonas aeruginosa","volume":"6","author":"Porto","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2025.04.010_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071717","article-title":"Reactive-oxygen-species-mediated P. aeruginosa killing is functional in Human cystic fibrosis macrophages","volume":"8","author":"Cifani","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jgar.2025.04.010_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00725-2022","article-title":"Elexacaftor\/tezacaftor\/ivacaftor corrects monocyte microbicidal deficiency in cystic fibrosis","volume":"61","author":"Cavinato","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jgar.2025.04.010_bib0008","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jgar.2025.04.010_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01935-23","article-title":"Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor","volume":"15","author":"Reasoner","year":"2024","journal-title":"MBio"},{"key":"10.1016\/j.jgar.2025.04.010_bib0010","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.3390\/ijms24055010","article-title":"Revisiting host-pathogen interactions in cystic fibrosis lungs in the era of CFTR modulators","volume":"24","author":"Ribeiro","year":"2023","journal-title":"IJMS"},{"key":"10.1016\/j.jgar.2025.04.010_bib0011","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1055\/s-0042-1758732","article-title":"Microbial epidemiology of the Cystic Fibrosis Airways: past, present, and future","volume":"44","author":"Thornton","year":"2023","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.jgar.2025.04.010_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1525-1470.2008.00620.x","article-title":"Cutaneous manifestations of Cystic fibrosis","volume":"25","author":"Bernstein","year":"2008","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jgar.2025.04.010_bib0013","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3390\/antibiotics12020217","article-title":"Antibiotic resistance in patients with Cystic Fibrosis: past, present, and future","volume":"12","author":"Perikleous","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.04.010_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2023.100106","article-title":"High throughput determination of the biofilm prevention concentration for Pseudomonas aeruginosa biofilms using a synthetic cystic fibrosis sputum medium","volume":"5","author":"De Bleeckere","year":"2023","journal-title":"Biofilm"},{"key":"10.1016\/j.jgar.2025.04.010_bib0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41522-022-00346-4","article-title":"Biofilm antimicrobial susceptibility through an experimental evolutionary lens","volume":"8","author":"Coenye","year":"2022","journal-title":"Npj Biofilms Microbiomes"},{"key":"10.1016\/j.jgar.2025.04.010_bib0016","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00194-23","article-title":"Cefiderocol treatment for patients with multidrug- and carbapenem-resistant Pseudomonas aeruginosa infections in the compassionate use program","volume":"67","author":"Satlin","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0017","doi-asserted-by":"crossref","first-page":"538.e7","DOI":"10.1016\/j.cmi.2022.11.014","article-title":"Cefiderocol resistance genomics in sequential chronic Pseudomonas aeruginosa isolates from cystic fibrosis patients","volume":"29","author":"L\u00f3pez-Causap\u00e9","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jgar.2025.04.010_bib0018","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00550-21","article-title":"The impact of bacterial biofilms on end-organ disease and mortality in patients with hematologic malignancies developing a bloodstream infection","volume":"9","author":"Di Domenico","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2025.04.010_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioflm.2024.100222","article-title":"Staphylococcus aureus colonizing the skin microbiota of adults with severe atopic dermatitis exhibits genomic diversity and convergence in biofilm traits","volume":"8","author":"Sivori","year":"2024","journal-title":"Biofilm"},{"key":"10.1016\/j.jgar.2025.04.010_bib0020","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1093\/bioinformatics\/btv271","article-title":"kSNP3.0: SNP detection and phylogenetic analysis of genomes without genome alignment or reference genome","volume":"31","author":"Gardner","year":"2015","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jgar.2025.04.010_bib0021","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1093\/molbev\/msab293","article-title":"eggNOG-mapper v2: functional annotation, orthology assignments, and domain prediction at the metagenomic scale","volume":"38","author":"Cantalapiedra","year":"2021","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.jgar.2025.04.010_bib0022","doi-asserted-by":"crossref","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","article-title":"Open-access bacterial population genomics: bIGSdb software, the PubMLST.Org website and their applications","volume":"3","author":"Jolley","year":"2018","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.jgar.2025.04.010_bib0023","doi-asserted-by":"crossref","first-page":"D690","DOI":"10.1093\/nar\/gkac920","article-title":"CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database","volume":"51","author":"Alcock","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jgar.2025.04.010_bib0024","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fmicb.2020.00037","article-title":"FeGenie: a comprehensive tool for the identification of iron genes and iron gene neighborhoods in genome and metagenome assemblies","volume":"11","author":"Garber","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.010_bib0025","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1093\/jac\/dkae126","article-title":"In vitro activity of cefiderocol in Pseudomonas aeruginosa isolates from people with cystic fibrosis recovered during three multicentre studies in Spain","volume":"79","author":"Maruri-Aransolo","year":"2024","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0026","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.3390\/ijms22063128","article-title":"Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors","volume":"22","author":"Jurado-Mart\u00edn","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jgar.2025.04.010_bib0027","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01968-17","article-title":"In vitro activity of the siderophore cephalosporin, cefiderocol, against carbapenem-nonsusceptible and multidrug-resistant isolates of gram-negative Bacilli collected worldwide in 2014 to 2016","volume":"62","author":"Hackel","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0028","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02646-20","article-title":"In vitro antibacterial activity of cefiderocol against multidrug-resistant Acinetobacter baumannii","volume":"65","author":"Abdul-Mutakabbir","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0029","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00351-22","article-title":"Role of extracellular DNA in dalbavancin activity against methicillin-resistant Staphylococcus aureus (MRSA) biofilms in patients with skin and soft tissue infections","volume":"10","author":"Sivori","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2025.04.010_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1432883","article-title":"Efficacy of sodium hypochlorite in overcoming antimicrobial resistance and eradicating biofilms in clinical pathogens from pressure ulcers","volume":"15","author":"Fabrizio","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2025.04.010_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/668770","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010","volume":"34","author":"Sievert","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jgar.2025.04.010_bib0032","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.diagmicrobio.2009.09.009","article-title":"Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients","volume":"66","author":"King","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2025.04.010_bib0033","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1093\/jpids\/piac052","article-title":"Opportunistic pathogens in cystic fibrosis: epidemiology and pathogenesis of lung infection","volume":"11","author":"Blanchard","year":"2022","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jgar.2025.04.010_bib0034","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s40121-023-00776-3","article-title":"Real-life data on the effectiveness and safety of cefiderocol in severely infected patients: a case series","volume":"12","author":"Fendian","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jgar.2025.04.010_bib0035","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s40265-019-1055-2","article-title":"Cefiderocol: a siderophore cephalosporin with activity against carbapenem-resistant and multidrug-resistant gram-negative Bacilli","volume":"79","author":"Zhanel","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.jgar.2025.04.010_bib0036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jgar.2019.12.009","article-title":"Resistance to ceftazidime\u2013avibactam and underlying mechanisms","volume":"22","author":"Wang","year":"2020","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2025.04.010_bib0037","doi-asserted-by":"crossref","first-page":"e00216","DOI":"10.1128\/aac.00216-22","article-title":"OXA-48-like \u03b2-lactamases: global epidemiology, treatment options, and development pipeline","volume":"66","author":"Boyd","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0038","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10096-021-04341-z","article-title":"In vitro activity of cefiderocol against ceftazidime-avibactam susceptible and resistant KPC-producing enterobacterales: cross-resistance and synergistic effects","volume":"41","author":"Bianco","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2025.04.010_bib0039","doi-asserted-by":"crossref","first-page":"ofab311","DOI":"10.1093\/ofid\/ofab311","article-title":"Cefiderocol activity against clinical Pseudomonas aeruginosa isolates exhibiting ceftolozane-tazobactam resistance","volume":"8","author":"Simner","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2025.04.010_bib0040","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00039-22","article-title":"Impact of acquired broad-spectrum \u03b2-lactamases on susceptibility to cefiderocol and newly developed \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in Escherichia coli and Pseudomonas aeruginosa","volume":"66","author":"Poirel","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0041","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1093\/jac\/dkac221","article-title":"Evolution of \u03b2-lactamase-mediated cefiderocol resistance","volume":"77","author":"Fr\u00f6hlich","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0042","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3390\/antibiotics11121681","article-title":"Synergistic effect of clinically available beta-lactamase inhibitors combined with cefiderocol against carbapenemase-producing gram-negative organisms","volume":"11","author":"Bianco","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.jgar.2025.04.010_bib0043","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3390\/cells13161315","article-title":"Synergistic activity of cefiderocol in combination with avibactam, sulbactam or tazobactam against carbapenem-resistant gram-negative bacteria","volume":"13","author":"Lewis","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jgar.2025.04.010_bib0044","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13756-019-0533-3","article-title":"Antibiotics versus biofilm: an emerging battleground in microbial communities","volume":"8","author":"Sharma","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.jgar.2025.04.010_bib0045","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00951-20","article-title":"Cefiderocol antimicrobial susceptibility testing considerations: the Achilles\u2019 Heel of the Trojan Horse?","volume":"59","author":"Simner","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jgar.2025.04.010_bib0046","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/jac\/dkab280","article-title":"Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia","volume":"76","author":"Katsube","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2025.04.010_bib0047","doi-asserted-by":"crossref","unstructured":"Jorth P., Galdino A.C., Vaillancourt M., Celedonio D., Huse K., Doi Y., et al. Evolved bacterial siderophore-mediated antibiotic cross-protection 2023. https:\/\/doi.org\/10.21203\/rs.3.rs-2644953\/v1.","DOI":"10.21203\/rs.3.rs-2644953\/v1"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000827?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716525000827?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:24:28Z","timestamp":1778858668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716525000827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S2213716525000827"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2025.04.010","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefiderocol activity against planktonic and biofilm forms of \u03b2-lactamase-producing pseudomonas aeruginosa from people with cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2025.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}